Development pathways for bringing gene and cell therapies from the lab to patients
Gene and cell therapies are evolving rapidly and show promise for treating many diseases and conditions. Hurdles remain in bringing safe, efficacious and high quality medicines based on genes, cells or tissues - Advanced Therapy Medicinal Products (ATMPs) - to patients in a timely manner.
EuroGCT aims to provide the research and regulatory communities with reliable and accessible information on the practical steps needed for gene and cell therapy development while promoting information exchange within and between these communities.
As this initiative develops, we begin with signposting to existing resources for guidance at each stage of development and will go on to fill information gaps identified in the field with expert-reviewed material. We hope to promote the free flow of knowledge to facilitate informed decision-making for researchers and regulators developing new therapies.